The University of Portland announced Tuesday that it will require COVID-19 booster shots for students, staff and faculty.

The private Portland university joins other schools that have made the shift to requiring boosters in the past few weeks including the University of Oregon, Oregon State University and Southern Oregon University.

THANKS TO OUR SPONSOR:
University of Portland Campus

University of Portland Campus

Hanin Najjar / OPB

Other private institutions such as Lewis & Clark College and Pacific University have also announced booster requirements. Willamette University announced its booster requirement late last week after initially only encouraging boosters.

The University of Portland set Feb. 1 as its booster deadline.

“Throughout the COVID-19 pandemic, two principles have guided our efforts: First, promoting the health and well-being of UP community members, and second, living out our mission as a face-to-face, residential institution,” UP Provost and Acting President Herbert Medina said in a statement. “The measures we announce today are intended to help us achieve both goals and safely return to campus for our new academic term. I am confident that with continued vigilance and adherence to our COVID-19 protocols, the coming semester will be just as successful as the last.”

Along with the booster requirement, the University of Portland will also start the first week of its new term online as an additional precaution against COVID-19 spread. Willamette University is also implementing a similar “quiet period.”

UP’s spring semester begins Monday, Jan. 10.

THANKS TO OUR SPONSOR:
THANKS TO OUR SPONSOR:
THANKS TO OUR SPONSOR:

Related Stories

Gov. Brown pleads ‘Get your booster,’ warning Oregonians have three weeks to prepare for omicron wave

Governor Kate Brown warned Oregonians that an OHSU forecast predicts the state's hospitals could be rapidly overwhelmed by omicron, even if though the variant causes milder illness. The state is responding with a plan to get booster shots to one million Oregonians; focus those shots on older, vulnerable people; create new sites to deliver monoclonal therapies and antiviral drugs; and attract more health care staff.